US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Clinuvel Pharmaceuticals Ltd.

7.22

0.0000

Volume:- -

Turnover:- -

Market Cap:360.62M

PE:15.16

High:7.22

Open:7.22

Low:7.22

Close:7.22

Loading ...

Overview Company News Filings

Company Profile

Company Name:

Clinuvel Pharmaceuticals Ltd.

Exchange:

PINK

Establishment Date:

1999

Employees:

16

Office Location:

535 Bourke Street,Level 22,Melbourne,Victoria,Australia

Website:

http://www.clinuvel.com

Zip Code:

3000

Phone:

Fax:

61 3 9660 4909

Introduction:

Clinuvel Pharmaceuticals Limited, a biopharmaceutical company, focuses on developing and commercializing treatments for patients with genetic, metabolic, and life-threatening disorders in Australia, Europe, the United States, Switzerland, and internationally. Its lead drug candidate is SCENESSE, a systemic photoprotective drug for the prevention of phototoxicity in adult patients with erythropoietic protoporphyria (EPP). The company's pipeline products include CUV9900, an alpha-melanocyte stimulating hormone analogue; Parvysmelanotide (VLRX001), which provoke prolonged cellular activity; and PRÉNUMBRA, a liquid injectable formulation of afamelanotide. The company was founded in 1987 and is headquartered in Melbourne, Australia.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/CLVLF/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CLVLF","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CLVLF\",,,,,undefined,":{"symbol":"CLVLF","market":"US","secType":"STK","nameCN":"Clinuvel Pharmaceuticals Ltd.","latestPrice":7.22,"timestamp":1750449600000,"preClose":7.22,"halted":0,"volume":0,"delay":15,"floatShares":41256001,"shares":49946800,"eps":0.476171,"marketStatus":"Market Closed","change":0,"latestTime":"06-20 16:00:00 EDT Delay","open":7.22,"high":7.22,"low":7.22,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":0.476171,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1750665600000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"PINK","adjPreClose":7.22,"volumeRatio":0.046283439785244844},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CLVLF\",,,,,undefined,":{"symbol":"CLVLF","floatShares":41256001,"roa":"14.22%","roe":"19.59%","lyrEps":0.477115,"volumeRatio":0.046283439785244844,"shares":49946800,"dividePrice":0.045618,"high":7.22,"amplitude":0,"preClose":7.22,"low":7.22,"week52Low":6.9,"pbRate":"2.57","psRate":"6.12","week52High":11.55,"institutionHeld":0,"latestPrice":7.22,"eps":0.476171,"divideRate":0.006318,"volume":0,"delay":15,"ttmEps":0.476171,"open":7.22,"prevYearClose":8.45,"prevWeekClose":7.22,"prevMonthClose":6.95,"prevQuarterClose":7.445,"fiveDayClose":7.22,"twentyDayClose":6.95,"sixtyDayClose":7.445},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":6117181,"yearFounded":1999,"employeeNum":16,"address":"535 Bourke Street,Level 22,Melbourne,Victoria,Australia","zipCode":"3000","officePhone":"61 3 9660 4900","officeFax":"61 3 9660 4909"},"stockCompanyDetail":{"websiteUrl":"http://www.clinuvel.com","stockEarnings":[{"period":"1week","weight":0.4712},{"period":"1month","weight":0.4661},{"period":"3month","weight":0.0494},{"period":"6month","weight":0.3551},{"period":"1year","weight":0.9434},{"period":"ytd","weight":0.9897}],"description":"Clinuvel Pharmaceuticals Limited, a biopharmaceutical company, focuses on developing and commercializing treatments for patients with genetic, metabolic, and life-threatening disorders in Australia, Europe, the United States, Switzerland, and internationally. Its lead drug candidate is SCENESSE, a systemic photoprotective drug for the prevention of phototoxicity in adult patients with erythropoietic protoporphyria (EPP). The company's pipeline products include CUV9900, an alpha-melanocyte stimulating hormone analogue; Parvysmelanotide (VLRX001), which provoke prolonged cellular activity; and PRÉNUMBRA, a liquid injectable formulation of afamelanotide. The company was founded in 1987 and is headquartered in Melbourne, Australia.","exchange":"PINK","name":"Clinuvel Pharmaceuticals Ltd.","nameEN":"Clinuvel Pharmaceuticals Ltd."}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"CLVLF\",market:\"US\",,,undefined,":null,"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CLVLF\",params:#limit:5,,,undefined,":[{"date":"2024-09-05","symbol":"CLVLF","amount":0.071429,"announcedDate":"2024-08-29","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-09-06","defaultRemindTime":1725543000000,"name":"Clinuvel Pharmaceuticals Ltd.","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-09-20","payableDate":"2024-09-06","currency":"AUD","dateTimestamp":1725508800000,"payDate":"2024-09-20"},{"date":"2023-09-05","symbol":"CLVLF","amount":0.071429,"announcedDate":"2023-08-29","type":"dividend","market":"US","newRecordDate":"2023-09-06","defaultRemindTime":1693920600000,"name":"Clinuvel Pharmaceuticals Ltd.","recordDate":"2023-09-20","payableDate":"2023-09-06","currency":"AUD","dateTimestamp":1693886400000,"payDate":"2023-09-20"},{"market":"US","date":"2022-09-06","symbol":"CLVLF","amount":0.057143,"defaultRemindTime":1662471000000,"name":"Clinuvel Pharmaceuticals Ltd.","recordDate":"2022-09-21","payableDate":"2022-09-07","currency":"AUD","type":"dividend","dateTimestamp":1662436800000},{"market":"US","date":"2021-09-02","symbol":"CLVLF","amount":0.025,"defaultRemindTime":1630589400000,"name":"Clinuvel Pharmaceuticals Ltd.","recordDate":"2021-09-17","payableDate":"2021-09-03","currency":"AUD","type":"dividend","dateTimestamp":1630555200000},{"market":"US","date":"2020-09-03","symbol":"CLVLF","amount":0.025,"name":"Clinuvel Pharmaceuticals Ltd.","recordDate":"2020-09-18","payableDate":"2020-09-04","currency":"AUD","type":"dividend","dateTimestamp":1599105600000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CLVLF\",market:\"US\",,,undefined,":[{"executeDate":"2019-09-04","recordDate":"2019-09-05","paymentDate":"2019-09-19","value":0.025,"currency":"AUD"},{"executeDate":"2020-09-03","recordDate":"2020-09-04","paymentDate":"2020-09-18","value":0.025,"currency":"AUD"},{"executeDate":"2021-09-02","recordDate":"2021-09-03","paymentDate":"2021-09-17","value":0.025,"currency":"AUD"},{"executeDate":"2022-09-06","recordDate":"2022-09-07","paymentDate":"2022-09-21","value":0.057143,"currency":"AUD"},{"executeDate":"2023-09-05","recordDate":"2023-09-06","paymentDate":"2023-09-20","value":0.071429,"currency":"AUD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CLVLF\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4,"buy":0.6,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6,"analysts":5,"updateTime":1729915200000}}}